ID

17835

Beschreibung

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK A 24 week double-blind, randomized, placebo-controlled, parallel-group dose-raging study to investigate the effects of rosiglitazone (extended release tablets) on cognition in subjects with mild to moderate Alzheimer´s disease. Medicine: rosiglitazone, Condition: Alzheimer´s Disease, Phase: 2, Clinical Study ID: AVA 100193, Sponsor: GSK. This ODM contains the Pharmacogenetic and Pharmacogenomic Research.

Stichworte

Versionen (2)
  1. 04.10.16 04.10.16 -
  2. 05.12.16 05.12.16 -
Hochgeladen am

4. Oktober 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Pharmacogenetic and Pharmacogenomic Research

Englisch

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Pharmacogenetic and Pharmacogenomic Research

1 Formulare  
General Information
Beschreibung

General Information

Protocol Identifier: AVA100193
Beschreibung

Protocol Identifier

Datentyp

boolean

Subject Identifier
Beschreibung

Subject Identifier

Datentyp

integer

PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research
Beschreibung

PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research

Has informed consent been obtained for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research?
Beschreibung

Informed Consent

Datentyp

boolean

If yes, record the date informed consent obtained for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research
Beschreibung

Date

Datentyp

date

If no, select one reason
Beschreibung

Reason for not obtaining informed consent

Datentyp

text

If Other, please specify
Beschreibung

Specification of Other

Datentyp

text

Blood sample collection (DNA)
Beschreibung

Blood sample collection (DNA)

Has a blood sample been collected for PGx-pharmacogenetic research?
Beschreibung

Has a blood sample been collected for PGx-pharmacogenetic research?

Datentyp

boolean

If yes, record the date samples taken.
Beschreibung

Date

Datentyp

date

Withdrawal of consent
Beschreibung

Withdrawal of consent

Has subject withdrawn consent for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research?
Beschreibung

Has subject withdrawn consent for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research?

Datentyp

boolean

Blood sample Destruction
Beschreibung

Blood sample Destruction

Has a request been made for sample destruction?
Beschreibung

Has a request been made for sample destruction?

Datentyp

boolean

If yes, specify reason
Beschreibung

If yes, specify reason

Datentyp

text

If other, please specify
Beschreibung

Other

Datentyp

text

Alias
UMLS CUI [1]
C0205394
Zum Seitenanfang zurückkehren

Ähnliche Modelle

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Pharmacogenetic and Pharmacogenomic Research

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
General Information
Protocol Identifier
Item
Protocol Identifier: AVA100193
boolean
Subject Identifier
Item
Subject Identifier
integer
Item Group
PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research
Informed Consent
Item
Has informed consent been obtained for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research?
boolean
Date
Item
If yes, record the date informed consent obtained for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research
date
Item
If no, select one reason
text
Reason for not obtaining informed consent
Code List
If no, select one reason
CL Item
Subject declined (1)
CL Item
Subject not asked by Investigator  (2)
CL Item
Other (specify) (3)
Specification of Other
Item
If Other, please specify
text
Item Group
Blood sample collection (DNA)
Has a blood sample been collected for PGx-pharmacogenetic research?
Item
Has a blood sample been collected for PGx-pharmacogenetic research?
boolean
Date
Item
If yes, record the date samples taken.
date
Item Group
Withdrawal of consent
Has subject withdrawn consent for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research?
Item
Has subject withdrawn consent for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research?
boolean
Item Group
Blood sample Destruction
Has a request been made for sample destruction?
Item
Has a request been made for sample destruction?
boolean
Item
If yes, specify reason
text
If yes, specify reason
Code List
If yes, specify reason
CL Item
Subject requested (1)
CL Item
Other (specify) (2)
Other
Item
If other, please specify
text
C0205394 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video